ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

PLSE Pulse Biosciences Inc

7.19
0.00 (0.00%)
시간외 단일가
최종 업데이트: 17:24:17
15분 지연
기업명 주식 심볼 시장 주식 타입
Pulse Biosciences Inc PLSE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 7.19 17:24:17
개장가 저가 고가 종가 전일 종가
7.19
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202405:05BWPulse Biosciences Schedules First Quarter 2024 Financial..
29/03/202405:12BWPulse Biosciences Reports Business Updates and Fourth..
29/03/202405:10BWPulse Biosciences Announces Plans to Initiate a Rights..
15/03/202405:05BWPulse Biosciences Schedules Fourth Quarter & Full Year 2023..
11/03/202422:10EDGAR2Form 8-K - Current report
09/03/202403:17BWPulse Biosciences Announces FDA 510(k) Clearance for its..
14/02/202423:22EDGAR2Form 8-K - Current report
14/02/202422:00BWPulse Biosciences Announces Positive 60-Day Follow-Up..
31/01/202422:00BWPulse Biosciences Announces Preliminary Findings from its..
09/01/202423:20EDGAR2Form 8-K - Current report
02/01/202423:20EDGAR2Form 8-K - Current report
02/01/202422:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
22/12/202323:08EDGAR2Form 8-K - Current report
20/12/202323:06EDGAR2Form 8-K - Current report
20/12/202322:00BWPulse Biosciences Announces First-in-Human Procedures with..
28/11/202307:29EDGAR2Form DEF 14A - Other definitive proxy statements
27/11/202323:08EDGAR2Form 8-K - Current report
21/11/202323:03EDGAR2Form 8-K - Current report
21/11/202322:00BWPulse Biosciences Files 510(k) Submission with U.S. FDA for..
17/11/202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202306:05BWPulse Biosciences to Present at the 35th Annual Piper..
14/11/202307:21EDGAR2Form PRE 14A - Other preliminary proxy statements
14/11/202307:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202323:12EDGAR2Form 8-K - Current report
13/11/202322:00BWPulse Biosciences Reports Business Updates and Third Quarter..
11/11/202306:56BWUPDATE Pulse Biosciences Announces New Time for Third..
04/11/202306:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202305:05BWPulse Biosciences Schedules Third Quarter 2023 Financial..
24/10/202321:00BWPulse Biosciences Appoints Dr. Niv Ad as Chief Science..
02/10/202321:00BWPulse Biosciences Announces Collaboration with CardioNXT for..
29/09/202321:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
27/09/202321:00BWPulse Biosciences’ First Study in a Surgical Application of..
12/09/202322:15EDGAR2Form 8-K - Current report
08/09/202305:05BWPulse Biosciences to Present at Gilmartin Group Emerging..
31/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
25/08/202305:05BWPulse Biosciences Clarifies Details of Recent S-3 Filing
12/08/202305:49EDGAR2Form S-3 - Registration statement under Securities Act of..
11/08/202305:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202305:14EDGAR2Form 8-K - Current report
11/08/202305:05BWPulse Biosciences Reports Business Updates and Second..
28/07/202305:05BWPulse Biosciences Schedules Second Quarter 2023 Financial..
20/07/202322:25EDGAR2Form 8-K - Current report
15/07/202309:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/07/202309:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/05/202320:00BWPulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™)..
12/05/202305:05BWPulse Biosciences Reports Business Updates and First Quarter..
10/05/202322:29BWPulse Biosciences, Inc. Announces Planned Redemption of..
03/05/202321:00BWPulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief..

최근 히스토리

Delayed Upgrade Clock